- Home
- ANNX vs NGS Comparison
ANNX vs NGS Comparison
Compare ANNX & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- NGS
- Stock Information
- Founded
- ANNX 2011
- NGS 1998
- Country
- ANNX United States
- NGS United States
- Employees
- ANNX N/A
- NGS N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- ANNX Health Care
- NGS Energy
- Exchange
- ANNX Nasdaq
- NGS Nasdaq
- Market Cap
- ANNX 334.1M
- NGS 328.4M
- IPO Year
- ANNX 2020
- NGS 2002
- Fundamental
- Price
- ANNX $3.00
- NGS $27.65
- Analyst Decision
- ANNX Strong Buy
- NGS Strong Buy
- Analyst Count
- ANNX 4
- NGS 3
- Target Price
- ANNX $13.00
- NGS $33.67
- AVG Volume (30 Days)
- ANNX 2.1M
- NGS 53.4K
- Earning Date
- ANNX 11-13-2025
- NGS 11-13-2025
- Dividend Yield
- ANNX N/A
- NGS 1.45%
- EPS Growth
- ANNX N/A
- NGS 33.85
- EPS
- ANNX N/A
- NGS 1.42
- Revenue
- ANNX N/A
- NGS $164,109,000.00
- Revenue This Year
- ANNX N/A
- NGS $9.86
- Revenue Next Year
- ANNX N/A
- NGS $14.21
- P/E Ratio
- ANNX N/A
- NGS $19.44
- Revenue Growth
- ANNX N/A
- NGS 14.77
- 52 Week Low
- ANNX $1.29
- NGS $16.73
- 52 Week High
- ANNX $7.74
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- ANNX 51.42
- NGS 56.40
- Support Level
- ANNX $2.87
- NGS $25.71
- Resistance Level
- ANNX $3.36
- NGS $26.76
- Average True Range (ATR)
- ANNX 0.21
- NGS 0.91
- MACD
- ANNX -0.03
- NGS 0.00
- Stochastic Oscillator
- ANNX 25.24
- NGS 90.19
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.